Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs041180122Phase 3Completed
Phase 3, randomised, open-label trial in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Ministry of Health, Labour and Welfare. Primary endpoint: Event-free survival. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs041180122.